Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

Pharmacology, Toxicology and Pharmaceutical Science

• Antihypertensive Therapy 100%
• Renovascular Hypertension 50%
• Fibromuscular Dysplasia 50%
• Long Acting Drug 50%

Keyphrases

• Diastolic Hypertension 33%
• Single-pill Combination 33%
• Renovascular Hypertension 33%
• Fibromuscular Dysplasia 33%
• Long-acting Agents 33%

Medicine and Dentistry

• Long Acting Drug 33%
• Fibromuscular Dysplasia 33%
• Renovascular Hypertension 33%